NCBiotech News

Wake Tech Community College recently launched a campaign, Building Tomorrow’s Talent, seeking industry partners to support the new biotech building on its RTP campus.

Durham gene therapy company Kriya Therapeutics has purchased neighboring startup Warden Bio, for an undisclosed sum, to expand its rare diseases capabilities.

Marrone Bio Innovations, a publicly traded company focused on sustainable bioprotection and plant health solutions, has relocated its corporate headquarters from Davis, Calif., to Raleigh.

Supported by a grant from NCBiotech, research team at Appalachian State University is investigating effective treatments for one of the most aggressive types of breast cancer — with the goal of reducing adverse side effects.

Thermo Fisher Scientific, Inc. has completed its acquisition of Wilmington-based global contract research organization PPD. The $17.4 million deal was finalized in December.

Developers have announced plans to build a $1 billion, 109-acre mixed-use life sciences campus in the heart of Morrisville, to be called Spark.

The Yield, a life sciences campus focusing on biomanufacturing, office and lab space with retail amenities, is about to get an official groundbreaking on 200 acres in Holly Springs.

Greensboro-based URO-1, an innovator of medical devices for urology and urogynecology, has achieved multiple milestones toward commercializing its products for prostate biopsy and other procedures.

Life sciences-related expansions, relocations or new facilities representing almost $4 billion in investment and 4,800 jobs were announced across the state in 2021.

A publicly traded clinical research and testing company, Science 37, will be moving its headquarters to Morrisville, creating some 250 new jobs in the next several years.

Morrisville-based Heat Biologics has signed a definitive merger agreement to acquire Elusys Therapeutics, a biodefense company that makes a treatment for anthrax, a deadly infectious disease potentially spread by bioterrorism or biowarfare.

A new national public/private consortium designed to boost the development of gene therapies also holds promise for North Carolina, as a major global leader in cell and gene therapies.

Morrisville-based Metabolon, a metabolomics data and insights company, will work with two major medical centers in Boston to study the biology underlying lactation for better maternal and infant health.

Marken, a global logistics company that serves the pharmaceutical and life sciences sectors, has expanded its headquarters and regional distribution operations in Durham to meet growing demand for shipment of clinical drug supplies, especially cell and gene therapies.

NCBiotech and a statewide coalition of partners are a Phase 1 recipient of up to $500,000 in the U.S. EDA’s $1 billion Build Back Better Regional Challenge.